DocDollars

Seqirus USA Inc

NJ · United States · Reporting entity ID 100000136554

Total reported 2019–2025
$91.5M
#104 of 2,960 reporting companies — 0.1% of all reported industry payments
$1.63M in general payments across 31,338 records, plus $89.9M in research funding across 51,320 records.

How it breaks down

General payments $1,625,421
Research funding $89,901,707

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Seqirus USA Inc reported $91.5M to US doctors and teaching hospitals from 2019 to 2025, ranking #104 of 2,960 reporting companies. 98% of that was research funding and 2% general payments such as consulting, speaking, food and travel. 31,338 general payment records and 51,320 research records were filed.

Common questions about Seqirus USA Inc

How much has Seqirus USA Inc paid US doctors?

Seqirus USA Inc reported $91,527,127 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,625,421 in general payments, $89,901,707 in research funding.

How does Seqirus USA Inc rank among drug and device companies?

It ranks #104 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Seqirus USA Inc mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.